Agios Pharma (AGIO) PT Raised to $44 at BofA Securities

March 31, 2026 9:48 AM

BofA Securities analyst Alec W. Stranahan raised the price target on Agios Pharma (NASDAQ: AGIO) to $44.00 (from $35.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found